Search

Displaying all 6 results
DrugBest match

Crisaborole

go.drugbank.com/drugs/DB05219
ApprovedInvestigational

Crisaborole is a novel oxaborole approved by FDA on December 14, 2016 as Eucrisa, a topical treatment of for mild to moderate atopic dermatitis. This non-steroidal agent is efficacious in improving disease severity, reducing the risk of infection and reducing the signs and symptoms in patients 2 years old and older....

  1. Pathway

    Crisaborole Drug Metabolism

    smpdb.ca/view/SMP0130654
    Metabolic

    Crisaborole passes through the liver and is then excreted from the body mainly through the kidney. … Crisaborole is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis.

    Drugs: Crisaborole
  2. Drug

    Apremilast

    go.drugbank.com/drugs/DB05676
    ApprovedInvestigational

    It belongs to the same drug class as [Roflumilast] and [Crisaborole].[A181244,L7495] Initially approved in 2014, it is marketed by Celgene.

  3. Drug

    PF-07038124

    go.drugbank.com/drugs/DB19143
    Investigational

    PF-07038124 is under investigation in clinical trial NCT05298033 (Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo).

  4. Indication

    Mild Atopic dermatitis

    go.drugbank.com/conditions/DBCOND0025273
    Drugs: Crisaborole · Desonide · Fusidic acid · Pimecrolimus · Roflumilast · Ruxolitinib
  5. Indication

    Moderate Atopic dermatitis

    go.drugbank.com/conditions/DBCOND0025271
    Drugs: Abrocitinib · Baricitinib · Crisaborole · Desonide · Dupilumab · Fusidic acid +5 more